The European Venture Report covers dealmaking, exits and fundraising trends shaping the VC landscape across the continent. This edition spotlights the pharma & biotech sector and touches on trends such as extensive CVC participation in European deals and the dominant role software plays in the VC ecosystem. Figures of note from the 2Q edition include:

  • €8.1 billion was invested across nearly 1,100 deals this quarter, marking Europe’s highest quarterly deal value on record

  • After unprecedented IPO activity in 2018, only 14 public listings worth €840.0 million closed in 1H 2019

  • €5.3 billion poured into 40 funds in 1H, signalling a stabilisation within the fundraising environment


Sign up with your email address to receive the latest newsletter.


Leave a reply

Your email address will not be published. Required fields are marked *


Talk to us to apply for loans through the government-backed CBILS scheme


©2021 E2Exchange - Conceptualized and Developed by TechShu

Log in with your credentials

Forgot your details?